Founded in 2012 by Rich G. Carter and Michael C. Standen, ​Valliscor is a technology-driven, chemical manufacturing company that leverages a broad suite of developed technologies to provide innovative solutions for its customers in the pharmaceutical, semi-conductor and allied industries. Valliscor specializes in the commercial manufacture of high-value compounds containing the element fluorine – particularly materials that require production under specific requirements due to their regulated properties.

Valliscor harnesses licensed, developed & patented technologies to provide unique & cost-effective solutions for producing high value chemical entities. For the pharmaceutical industry, Valliscor manufactures key starting materials (KSM) to produce medications that treat asthma, chronic obstructive pulmonary disease (COPD), breast cancer and other diseases. Valliscor's etchant products for the semiconductor industry are used to make logic and memory chips. Valliscor also produces a fluorine-containing monomers for the polymer industry.

Valliscor’s corporate headquarters and initial manufacturing facility are located in Corvallis, Oregon. Valliscor’s Corvallis site is located within the Advanced Technology and Manufacturing Institute (ATAMI), which offers a modern, well-equipped facility with access to extensive instrumentation services. More recently, Valliscor has acquired a 12+ acre greenfield site in neighboring Albany, Oregon where it is building its second manufacturing site. Valliscor broke ground on the campus in August 2025 with construction of the initial phase that includes a 16,000+ sq. ft. manufacturing facility and supporting structures.